• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含腙1,2,4-三嗪类抗惊厥剂的设计、合成及生物学评价

Design, synthesis, and biological evaluation of hydrazone incorporated 1,2,4-triazines as anticonvulsant agents.

作者信息

Amir Mohammed, Ali Israr, Hassan Mohd Zaheen, Mulakayala Naveen

机构信息

Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Hamdard University, New Delhi, India.

出版信息

Arch Pharm (Weinheim). 2014 Dec;347(12):958-68. doi: 10.1002/ardp.201400045. Epub 2014 Sep 24.

DOI:10.1002/ardp.201400045
PMID:25251582
Abstract

New hydrazone incorporated triazines were designed and synthesized using an appropriate synthetic route with regard to essential pharmacophores, and evaluated for their anticonvulsant activity through maximal electroshock seizure (MES) and subcutaneous pentylenetetrazole-induced seizure (scPTZ) screenings. Among the tested compounds, 4-[{2-(5-(3-chlorobenzyl)-3-phenyl-1,2,4-triazine-6-yl)hydrazono}methyl]-N,N-dimethylaniline 6k (MES ED50 54.31, scPTZ ED50 92.01) and 4-[{2-(5-(4-chlorobenzyl)-3-phenyl-1,2,4-triazine-6-yl)hydrazono}methyl]-N,N-dimethylaniline 6r (MES ED50 46.05, scPTZ ED50 83.90) emerged as the most active anticonvulsant agents having GABAergic effects. Compounds 6k and 6r also showed lesser CNS depressant effect than the standard drug carbamazepine. To obtain further insights into the binding interactions of these molecules, molecular docking studies were carried out.

摘要

设计并合成了新型含腙三嗪,采用合适的合成路线引入关键药效基团,并通过最大电休克惊厥(MES)和皮下注射戊四氮诱导惊厥(scPTZ)筛选评估其抗惊厥活性。在所测试的化合物中,4 - [{2 - (5 - (3 - 氯苄基)-3 - 苯基 - 1,2,4 - 三嗪 - 6 - 基)腙基}甲基]-N,N - 二甲基苯胺6k(MES ED50 54.31,scPTZ ED50 92.01)和4 - [{2 - (5 - (4 - 氯苄基)-3 - 苯基 - 1,2,4 - 三嗪 - 6 - 基)腙基}甲基]-N,N - 二甲基苯胺6r(MES ED50 46.05,scPTZ ED50 83.90)成为具有GABA能效应的最具活性的抗惊厥剂。化合物6k和6r与标准药物卡马西平相比,还表现出较小的中枢神经系统抑制作用。为了进一步深入了解这些分子的结合相互作用,进行了分子对接研究。

相似文献

1
Design, synthesis, and biological evaluation of hydrazone incorporated 1,2,4-triazines as anticonvulsant agents.含腙1,2,4-三嗪类抗惊厥剂的设计、合成及生物学评价
Arch Pharm (Weinheim). 2014 Dec;347(12):958-68. doi: 10.1002/ardp.201400045. Epub 2014 Sep 24.
2
Synthesis, Biological Activity, and Docking Study of Novel Isatin Coupled Thiazolidin-4-one Derivatives as Anticonvulsants.新型异吲哚酮偶联噻唑烷-4-酮衍生物作为抗惊厥剂的合成、生物活性及对接研究
Arch Pharm (Weinheim). 2015 Jun;348(6):433-45. doi: 10.1002/ardp.201500020. Epub 2015 Apr 22.
3
Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents.6-(2-氨基取代苯基)-4-(取代苯基)-1,2,4-三嗪-3,5(2H,4H)-二酮衍生物作为抗惊厥剂的设计、合成及生物学评价
Arch Pharm (Weinheim). 2016 Apr;349(4):277-92. doi: 10.1002/ardp.201500448. Epub 2016 Mar 21.
4
Synthesis, physicochemical, and anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl analog.源自吡咯烷-2,5-二酮及其3-甲基类似物的新型N-曼尼希碱的合成、物理化学性质及抗惊厥特性
Arch Pharm (Weinheim). 2014 Oct;347(10):768-76. doi: 10.1002/ardp.201400152. Epub 2014 Aug 19.
5
Design, Synthesis, and Docking Study of Pyrimidine-Triazine Hybrids for GABA Estimation in Animal Epilepsy Models.嘧啶三嗪杂合体的设计、合成与对接研究及其在动物癫痫模型中 GABA 估计的应用。
Arch Pharm (Weinheim). 2017 Sep;350(9). doi: 10.1002/ardp.201700146. Epub 2017 Jul 31.
6
Design and synthesis of anticonvulsants from a combined phthalimide-GABA-anilide and hydrazone pharmacophore.基于邻苯二甲酰亚胺 -γ-氨基丁酸 - 苯胺和腙药效团组合的抗惊厥药的设计与合成
Eur J Med Chem. 2007 Feb;42(2):146-51. doi: 10.1016/j.ejmech.2006.08.010. Epub 2006 Sep 28.
7
Design & synthesis of 2-(substituted aryloxy)-5-(substituted benzylidene)-3-phenyl-2,5-dihydro-1H-[1,2,4] triazin-6-one as potential anticonvulsant agents.设计与合成 2-(取代芳氧基)-5-(取代亚苄基)-3-苯基-2,5-二氢-1H-[1,2,4]三嗪-6-酮作为潜在的抗惊厥药物。
Eur J Med Chem. 2010 Sep;45(9):3960-9. doi: 10.1016/j.ejmech.2010.05.051. Epub 2010 Jun 1.
8
Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.喹唑啉-4(3H)-酮类化合物作为抗惊厥剂的结构探索:合理设计、合成、药理学评价及分子对接研究
Arch Pharm (Weinheim). 2016 Nov;349(11):864-880. doi: 10.1002/ardp.201600218. Epub 2016 Sep 28.
9
Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.源自N-苄基-2-(2,5-二氧代吡咯烷-1-基)丙酰胺和2-(2,5-二氧代吡咯烷-1-基)丁酰胺衍生物的新型杂合抗惊厥药的设计、合成及生物学评价
Bioorg Med Chem. 2015 May 15;23(10):2548-61. doi: 10.1016/j.bmc.2015.03.038. Epub 2015 Mar 21.
10
Synthesis and Anticonvulsant Activity of Substituted-1,3-diazaspiro[4.5]decan-4-ones.取代-1,3-二氮杂螺[4.5]癸烷-4-酮的合成及抗惊厥活性。
Arch Pharm (Weinheim). 2015 Aug;348(8):575-88. doi: 10.1002/ardp.201500092. Epub 2015 May 29.

引用本文的文献

1
Current Research on Antiepileptic Compounds.抗癫痫化合物的当前研究
Molecules. 2015 Nov 20;20(11):20741-76. doi: 10.3390/molecules201119714.